製藥和生物技術領域的生產和供應合約：2021-2026 年

本報告基於 1622 個案例的實際合約數據，揭示了製藥和生物技術公司如何建立生產和供應合作夥伴關係。

本報告提供了全球生命科學產業 1622 份製造和供應合約的全面資訊。

隨著製藥和生物技術公司尋求專業能力、額外的生產能力、靈活的生產系統、獲得新的製造技術以及從研發到商業化的整個過程中可靠的供應鏈，製造夥伴關係變得越來越重要。

本報告探討了公司如何建立這些關係，哪些組織特別活躍，哪些地區的交易高度集中，以及可以從披露的財務條款和公開的合約文件中檢驗什麼。

該報告不僅列出了交易，還有助於加深對哪些公司正在合作、正在利用哪些製造和供給能力、合約是如何建構的以及合作夥伴之間如何分配責任和商業性義務的理解。

本報告為業務發展、外部製造、營運、供應鏈、採購、聯盟管理、公司策略和法律團隊提供可操作的資訊來源和基準資源，以評估和談判製造和供應合作夥伴關係。

了解製造和供應合約的市場趨勢

本報告分析了2021年至2026年有關製造和供應合約的以下項目：

• 年度合約趨勢；合作時的發展階段；產業領域；治療領域；技術類型；擁有最活躍的生產和供應合約的公司；基於公開揭露金額的重大交易；進行生產和供應合作的策略原因；外包策略和生產策略的變化
• 這有助於了解哪些地區對外部製造能力的需求正在成長，以及哪些公司一再參與製造和供應合作關係。
• 了解製造和供應合約的結構
• 在製造和供應關係中，必須就營運責任、生產要求、品質、定價和供應連續性達成詳細協議。

本報告提供以下資訊供您參考：

• 生產責任
• 對生產和供應的承諾
• 技術轉移
• 擴大規模和商業化生產
• 對產能的承諾
• 產品規格
• 需求預測與訂購
• 定價和支付方式
• 最低採購義務/最低供應義務
• 品管和品質保證
• 監理合規責任
• 智慧財產權和製造技術
• 關於壟斷的協議
• 區域或產品特定權利
• 合約期限和終止條款
• 財務狀況（如公開資訊）
• 這些例子為建立和談判新的製造和供應關係提供了有用的參考資訊。
• 尋找潛在的製造和供應合作夥伴
• 對於尋求外部製造能力的公司而言，過去的交易記錄是了解潛在合作夥伴的重要資訊來源。
• 本報告重點介紹了製造和供應合約最活躍的前 25 家公司，提供交易歷史記錄，以識別在相關技術、產品類型和開發階段擁有良好業績記錄的公司。

目錄

摘要整理

第1章：引言

第2章：製造和供應合約的趨勢

• 製造和供應合約的定義
• 製造業和供應合約的趨勢
  • 年度製造和供應合約
  • 開發階段的製造和供應合約
  • 按行業分類的製造和供應合約
  • 按治療領域分類的生產和供應合約
  • 按技術類型分類的製造和供應合約
  • 最活躍的公司特定製造和供應合約
• 簽訂製造和供應合作協議的原因
• 製造業和供應合約的未來

第3章：製造和供應合約的結構：概述

• 製造和供應合約的結構

第4章 主要製造和供應合約

• 按合約金額分類的主要製造和供應合約

第5章：擁有最活躍製造和供應合約的前25家公司

• 擁有最活躍的製造和供應合約的前 25 家公司

第6章：製造和供應合約目錄（含合約）

• 可供審查的生產和供應合約。
• 合約目錄
• 交易目錄：按公司
• 交易目錄：依治療領域
• 交易目錄：依技術領域
• 關於生物製藥研究
• Current Partnering
• Current Agreements
• 理想合作夥伴近期報告標題

Understand how pharmaceutical and biotechnology companies structure manufacturing and supply partnerships using intelligence from 1,622 real-world deals.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides comprehensive intelligence on 1,622 manufacturing and supply deals across the global life sciences industry.

Manufacturing partnerships are increasingly important as pharmaceutical and biotechnology companies seek specialist capabilities, additional capacity, flexible production, access to new manufacturing technologies and reliable supply throughout development and commercialization.

The report examines how companies establish these relationships, which organizations are particularly active, where dealmaking is concentrated and what can be learned from disclosed financial terms and publicly available contract documents.

Rather than simply identifying transactions, the report helps users understand who is partnering, what manufacturing and supply capabilities are being accessed, how agreements are structured and how responsibilities and commercial obligations are allocated between partners.

It provides a practical intelligence and benchmarking resource for business development, external manufacturing, operations, supply chain, procurement, alliance management, corporate strategy and legal teams evaluating or negotiating manufacturing and supply partnerships.

Understand the manufacturing and supply deal landscape

The report analyzes manufacturing and supply dealmaking from 2021 to 2026, including:

• Trends in dealmaking by year
• Phase of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active manufacturing and supply dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering manufacturing and supply partnerships
• How outsourcing and manufacturing strategies are evolving
• This provides insight into where demand for external manufacturing capabilities is developing and which companies are repeatedly participating in manufacturing and supply partnerships.
• Understand how manufacturing and supply agreements are structured
• Manufacturing and supply relationships require detailed agreement over operational responsibilities, production requirements, quality, pricing and continuity of supply.

The report provides intelligence to help users examine areas including:

• Manufacturing responsibilities
• Production and supply commitments
• Technology transfer
• Scale-up and commercial manufacturing
• Capacity commitments
• Product specifications
• Forecasting and ordering
• Pricing and payment mechanisms
• Minimum purchase or supply obligations
• Quality control and quality assurance
• Regulatory and compliance responsibilities
• Intellectual property and manufacturing know-how
• Exclusivity arrangements
• Geographic or product-specific rights
• Term and termination provisions
• Financial terms where disclosed
• These real-world examples provide useful reference points when establishing or negotiating new manufacturing and supply relationships.
• Identify prospective manufacturing and supply partners
• For companies seeking external manufacturing capabilities, previous transaction activity can provide important intelligence on potential partners.
• The report profiles the Top 25 most active manufacturing and supply dealmakers and provides transaction histories that can help users identify organizations with demonstrated involvement across relevant technologies, product types and stages of development.

This can support:

• CMO and CDMO partner identification
• Manufacturing partner screening
• Outsourcing strategy
• Assessment of specialist capabilities
• Competitor and supplier intelligence
• Business development
• Supply-chain planning
• Deal histories can also help users understand which providers are actively expanding relationships within particular areas of pharmaceutical and biotechnology manufacturing.
• Benchmark leading deals and disclosed financial terms
• The report identifies leading manufacturing and supply transactions by disclosed deal value and provides access to available financial information associated with individual agreements.
• Where disclosed, users can investigate payment structures, investment commitments and other commercial terms to provide additional context when evaluating comparable manufacturing relationships.
• The objective is not simply to establish a headline transaction value, but to understand how real-world manufacturing partnerships have been structured commercially.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying manufacturing and supply contract documents.

These agreements can reveal substantially more detail than company announcements alone, enabling users to examine how selected parties have addressed matters including:

• Production obligations
• Supply commitments
• Pricing and payment
• Forecasting and ordering
• Quality and compliance
• Manufacturing specifications
• Intellectual property
• Exclusivity
• Liability
• Termination
• Continuity of supply
• For teams preparing or negotiating manufacturing agreements, these real-world contracts provide valuable insight into how comparable provisions have been documented in practice.
• Comprehensive manufacturing and supply deal directory
• The report includes a comprehensive directory of 1,622 manufacturing and supply deals, enabling users to identify transactions relevant to their own products, technologies and manufacturing requirements.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and External Partnering teams
• Identify potential manufacturing partners, relevant precedent transactions and companies with demonstrated capabilities.
• External Manufacturing and Operations teams
• Understand how other companies establish manufacturing relationships and allocate operational responsibilities.
• Supply Chain and Procurement teams
• Benchmark supply arrangements and investigate potential providers, commercial structures and contractual obligations.
• Biotechnology Companies Scaling Development
• Identify manufacturing organizations with relevant experience as programs move from development towards clinical and commercial production.
• Corporate and Manufacturing Strategy teams
• Track outsourcing activity and understand how companies are accessing specialist manufacturing technologies, capacity and capabilities.
• Alliance Management teams
• Examine how responsibilities, performance expectations and ongoing obligations have been structured across comparable partnerships.
• Legal and Transaction teams
• Review publicly available agreements and contractual approaches to support drafting, due diligence and negotiation.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying manufacturing and supply intelligence to the customer's own products, technologies, development programs or outsourcing requirements.
• Depending on requirements, this can include relevant comparable deals, prospective manufacturing or supply partners, competitor outsourcing activity, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

• 2.1. Introduction
• 2.2. Definition of manufacturing and supply deal
• 2.3. Trends in manufacturing and supply deals
  • 2.3.1. Manufacturing and supply dealmaking by year
  • 2.3.2. manufacturing and supply dealmaking by phase of development
  • 2.3.3. Manufacturing and supply dealmaking by industry sector
  • 2.3.4. Manufacturing and supply dealmaking by therapy area
  • 2.3.5. Manufacturing and supply dealmaking by technology type
  • 2.3.6. Manufacturing and supply dealmaking by most active company
• 2.4. Reasons for entering into manufacturing and supply partnering deals
• 2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

• 3.1. Introduction
• 3.2. manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

• 4.1. Introduction
• 4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

• 6.1. Introduction
• 6.2. manufacturing and supply deals with contracts
• Deal directory
• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of manufacturing and supply
• Figure 2: Trends in manufacturing and supply deal announcements
• Figure 3: Manufacturing and supply deals signed at each phase of development
• Figure 4: Manufacturing and supply deals by industry sector
• Figure 5: Manufacturing and supply deals by therapy area
• Figure 6: Manufacturing and supply deals by technology type
• Figure 7: Top 25 most active manufacturing and supply dealmakers
• Figure 8: Top manufacturing and supply deals by value
• Figure 9: Most active manufacturing and supply dealmakers